acetylcysteine has been researched along with Cochlear Hearing Loss in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chen, SL; Chin, SC; Ho, CY | 1 |
Angel, D; Franklin, J; Fung, K; Hamilton, SJ; Lewis, D; Parnes, LS; Venkatesan, V; Winquist, E; Yoo, J | 1 |
Abi-Hachem, RN; Angeli, SI; Machado, JJ; Telischi, FT; Vivero, RJ | 1 |
Kilic, MA; Kilinc, M; Okur, E; Tolun, FI; Yildirim, I | 1 |
Chua, AW; Low, WK; Sun, L; Tan, MG; Wang, DY | 1 |
Brown, RD; Henley, CM; Kupetz, S; Penny, JE | 1 |
1 review(s) available for acetylcysteine and Cochlear Hearing Loss
Article | Year |
---|---|
Link between functional and morphological changes in the inner ear--functional changes produced by ototoxic agents and their interactions.
Topics: Acetylcysteine; Adult; Aminoglycosides; Aminooxyacetic Acid; Anesthetics; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Aspirin; Child; Chloramphenicol; Cochlea; Cochlear Microphonic Potentials; Diuretics; Drug Synergism; Erythromycin; Evoked Potentials, Auditory; Glycerol; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Sensorineural; Humans; Labyrinth Diseases; Noise; Otitis Media; Rats; Stria Vascularis | 1985 |
1 trial(s) available for acetylcysteine and Cochlear Hearing Loss
Article | Year |
---|---|
Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.
Topics: Acetylcysteine; Adult; Audiometry; Auditory Threshold; Cisplatin; Feasibility Studies; Female; Follow-Up Studies; Head and Neck Neoplasms; Hearing Loss, Sensorineural; Humans; Injections, Intralesional; Male; Middle Aged; Prospective Studies; Reference Values; Risk Assessment; Treatment Outcome; Tympanic Membrane | 2014 |
4 other study(ies) available for acetylcysteine and Cochlear Hearing Loss
Article | Year |
---|---|
Effects of oral N-acetylcysteine combined with oral prednisolone on idiopathic sudden sensorineural hearing loss.
Topics: Acetylcysteine; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Prednisolone; Retrospective Studies; Treatment Outcome | 2022 |
L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Dexamethasone; Drug Therapy, Combination; Female; Free Radical Scavengers; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Tests; Humans; Male; Middle Aged; Prednisone; Retrospective Studies; Young Adult | 2012 |
Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Biomarkers; Carboplatin; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Follow-Up Studies; Free Radical Scavengers; Glutathione Peroxidase; Hearing Loss, Sensorineural; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Spectrophotometry; Treatment Outcome | 2007 |
L-N-Acetylcysteine protects against radiation-induced apoptosis in a cochlear cell line.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Line; Cochlea; Flow Cytometry; Free Radical Scavengers; Hearing Loss, Sensorineural; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Radiation Injuries, Experimental; Reactive Oxygen Species | 2008 |